Preventive effects of low-dose dexamethasone for delayed adverse events induced by carboplatin-based combination chemotherapy

Hitoshi Kawazoe, Yoshiharu Takiguchi, Hiroaki Tanaka, Chiaki Doi, Noriyasu Fukuoka, Nobuhiro Kanaji, Shuji Bandoh, Toshihiko Ishida, Hitoshi Houchi

研究成果: Article

4 引用 (Scopus)

抜粋

We performed a retrospective study to examine the protective effect of low-dose dexamethasone (DEX) on delayed adverse events induced by carboplatin (CBDCA)-based combination chemotherapy in patients with thoracic tumors. Low-dose DEX (4-8 mg/day) was administered on day 1 and after, in addition to a serotonin 5-HT3 receptor antagonist. The acute adverse events (day 1) were well controlled in the patients with or without co-treatment of DEX. On the other hand, the delayed nausea, emesis, anorexia, and fatigue after day 2 failed to be controlled by 5-HT3 antagonist alone. Co-treatment with DEX significantly suppressed the grade of the delayed adverse events during days 2-10. The mean ratio of complete protection during days 2-10 were significantly higher in the DEX-treated group compared with the non-DEX-treated group. These results reveal that low-dose DEX is a clinically effective treatment for the prevention of delayed adverse events induced by CBDCA-based combination chemotherapy.

元の言語English
ページ(範囲)1001-1006
ページ数6
ジャーナルYakugaku Zasshi
127
発行部数6
DOI
出版物ステータスPublished - 2007 6 1
外部発表Yes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

フィンガープリント Preventive effects of low-dose dexamethasone for delayed adverse events induced by carboplatin-based combination chemotherapy' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用

    Kawazoe, H., Takiguchi, Y., Tanaka, H., Doi, C., Fukuoka, N., Kanaji, N., Bandoh, S., Ishida, T., & Houchi, H. (2007). Preventive effects of low-dose dexamethasone for delayed adverse events induced by carboplatin-based combination chemotherapy. Yakugaku Zasshi, 127(6), 1001-1006. https://doi.org/10.1248/yakushi.127.1001